11 employees
Toralgen is a biopharmaceutical firm that provides the development and commercialization of human therapeutics.
2017
$8.3M
from 5 investors over 5 rounds
Toralgen raised $8.3M on December 14, 2020
Investors: Solyco Advisors and -
Toralgen raised $1.9M on September 10, 2019
Investors: Elevate Ventures, - and Solyco Advisors